|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR
Departments of Internal Medicine (S.T., T.G., J.D.M.) and Pharmacology and Toxicology (S.S., S.W.R., J.R.S., N.J.R.), College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
Calcium influx through long-lasting ("L-type") Ca2+ channels (CaV) drives excitation-contraction in the normal heart. Dysregulation of this process contributes to Ca2+ overload, and interventions that reduce expression of the pore-forming
1 subunit may alleviate cytosolic Ca2+ excess. As a molecular approach to disrupt the assembly of CaV1.2 (
1C) channels at the cell membrane, we targeted the Ca2+ channel β2 subunit, an intracellular chaperone that interacts with
1C via its β interaction domain (BID) to promote CaV1.2 channel expression. Recombinant adenovirus expressing either the full β2 subunit (Full-β2) or truncated β2 subunit constructs lacking either the C terminus, N terminus, or both (N-BID, C-BID, and BID, respectively) fused to green fluorescent protein were developed as potential decoys and overexpressed in HL-1 cells. Fluorescence microscopy revealed that the localization of Full-β2 at the surface membrane was associated with increased Ca2+ current mainly attributed to CaV1.2 channels. In contrast, truncated N-BID and C-BID constructs showed punctate intracellular expression, and BID showed a diffuse cytosolic distribution. Total expression of the
1C protein of CaV1.2 channels was similar between groups, but HL-1 cells overexpressing C-BID and BID exhibited reduced Ca2+ current. C-BID and BID also attenuated Ca2+ current associated with another L-type Ca2+ channel, CaV1.3, but they did not reduce transient Ca2+ currents attributed to CaV3 channels. These results suggest that β2 subunit mutants lacking the N terminus may preferentially disrupt the proper localization of L-type Ca2+ channels in the cell membrane. Cardiac-specific delivery of these decoy molecules in vivo may represent a gene-based treatment for pathologies involving Ca2+ overload.